Where Cell Therapy Innovation Meets Acceleration
CTMC offers fully integrated 360° Solutions combined with a patient-adjacent manufacturing model with The University of Texas MD Anderson Cancer Center.
We are so much more than a CDMO.
Minimizing Risk.
Accelerating Time to Clinic.
Maximizing Value.
By integrating development, manufacturing, and digital infrastructure into a unified BioSolutions platform, we reduce execution risk, preserve capital, and create earlier value inflection, giving investors, researchers, and biotech a clearer, faster path to patients.
Our 360° Solutions deliver the full suite of capabilities needed to transform groundbreaking science into clinical reality – faster, smarter, and all in one place.
BioSolutions
Comprehensive model to accelerate cell therapy from research to clinical
- Integrated manufacturing capabilities — from viral vector production to CAR-T, NK, and TIL therapies, all under one roof.
- Seamless, holistic solutions — guiding programs from early development through clinical trials to commercialization.
- Comprehensive, bundled expertise — uniting development, regulatory, clinical, and operational support to streamline progress to patients.
BioExpertise
- Collaborative team of scientists, specialists, and technicians blending deep academic insight with proven industrial expertise.
- Trailblazers in TIL therapy advancing innovative platforms, technologies, and manufacturing processes through our proprietary reagents and methods.
BioInnovation
- Sharing expertise and innovation through our Network Alliance, offering educational exchange, knowledge transfer, and proprietary process know-how.
- Opening doors to innovation with access to advanced technologies and proprietary reagents.
- Expanding global reach by democratizing cell therapy to make lifesaving treatments accessible worldwide.
Network Alliance
The CTMC Network Alliance delivers long-term value by offering members a comprehensive suite of services, materials, and products to advance cell therapy development. Through specialized training, educational programs, and readiness assessments, members gain the knowledge to implement cell therapies effectively and manufacture locally.
The CTMC Advantage
Simplifying the Path from Bench to Bedside
Unlike the fragmented traditional CMO model, CTMC provides a fully integrated partnership by uniting manufacturing, clinical, regulatory, and logistics under one roof. This seamless approach streamlines the path from preclinical proof-of-concept to clinical data, reducing complexity, timelines, and cost.
SQUARE FEET DEDICATED TO CELL THERAPY
cGMP CLEANROOMS
SQUARE FEET OF SUPPORTING LABS
Partnerships + Collaborations
Our partnership models support early-stage biotechs and academic teams with the expertise and infrastructure needed to move from idea to impact. Strategic collaborations with technology and materials innovators enable us to deliver more efficient, effective, and de-risked development and manufacturing solutions.
Why We Do What We Do
At CTMC, everything starts and ends with patients. Behind every therapy we develop and manufacture are dedicated experts with a passion for bringing new therapies to patients. This video offers a glimpse into our team at work, as they bring science to life with the shared purpose of delivering transformative cell therapies to those who need them most.
Recent News
How T Cell Activation Redefines TIL and CAR-T Manufacturing (Boosting Success Rates to 95%) with Chantale Bernatchez – Part 2
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from...
How T Cell Activation Redefines TIL and CAR-T Manufacturing (Boosting Success Rates to 95%) with Chantale Bernatchez – Part 1
The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the...
Base to Base biotech podcast #55: The circular supply chain
CTMC is a joint venture between Resilience and the MD Anderson Cancer Center. It works like an internal manufacturing group, adapting to change...
